636 related articles for article (PubMed ID: 26392491)
1. In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to Cefepime.
Pires J; Taracila M; Bethel CR; Doi Y; Kasraian S; Tinguely R; Sendi P; Bonomo RA; Endimiani A
Antimicrob Agents Chemother; 2015 Dec; 59(12):7483-8. PubMed ID: 26392491
[TBL] [Abstract][Full Text] [Related]
2. Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway.
Naseer U; Haldorsen B; Simonsen GS; Sundsfjord A
Clin Microbiol Infect; 2010 Feb; 16(2):171-8. PubMed ID: 19548922
[TBL] [Abstract][Full Text] [Related]
3. Increased expression levels of chromosomal AmpC β-lactamase in clinical Escherichia coli isolates and their effect on susceptibility to extended-spectrum cephalosporins.
Paltansing S; Kraakman M; van Boxtel R; Kors I; Wessels E; Goessens W; Tommassen J; Bernards A
Microb Drug Resist; 2015 Feb; 21(1):7-16. PubMed ID: 25188329
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum β-lactamase-producing E. coli in Japan.
Matsumura Y; Yamamoto M; Higuchi T; Komori T; Tsuboi F; Hayashi A; Sugimoto Y; Hotta G; Matsushima A; Nagao M; Takakura S; Ichiyama S
Int J Antimicrob Agents; 2012 Aug; 40(2):158-62. PubMed ID: 22743014
[TBL] [Abstract][Full Text] [Related]
5. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
[TBL] [Abstract][Full Text] [Related]
6. The occurrence of ESBL-producing Escherichia coli carrying aminoglycoside resistance genes in urinary tract infections in Saudi Arabia.
Alyamani EJ; Khiyami AM; Booq RY; Majrashi MA; Bahwerth FS; Rechkina E
Ann Clin Microbiol Antimicrob; 2017 Jan; 16(1):1. PubMed ID: 28061852
[TBL] [Abstract][Full Text] [Related]
7. Characterization of beta-lactamases responsible for resistance to extended-spectrum cephalosporins in Escherichia coli and Salmonella enterica strains from food-producing animals in the United Kingdom.
Liebana E; Gibbs M; Clouting C; Barker L; Clifton-Hadley FA; Pleydell E; Abdalhamid B; Hanson ND; Martin L; Poppe C; Davies RH
Microb Drug Resist; 2004; 10(1):1-9. PubMed ID: 15140388
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype.
Jørgensen RL; Nielsen JB; Friis-Møller A; Fjeldsøe-Nielsen H; Schønning K
J Antimicrob Chemother; 2010 Mar; 65(3):460-4. PubMed ID: 20097787
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and characterization of multidrug-resistant and extended-spectrum beta-lactamase-producing Escherichia coli from pediatric wards of a Malaysian hospital.
Ho WS; Balan G; Puthucheary S; Kong BH; Lim KT; Tan LK; Koh XP; Yeo CC; Thong KL
Microb Drug Resist; 2012 Aug; 18(4):408-16. PubMed ID: 22394084
[TBL] [Abstract][Full Text] [Related]
10. Characterization of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark.
Hansen F; Olsen SS; Heltberg O; Justesen US; Fuglsang-Damgaard D; Knudsen JD; Hammerum AM
Microb Drug Resist; 2014 Aug; 20(4):316-24. PubMed ID: 24517383
[TBL] [Abstract][Full Text] [Related]
11. Wild Birds, Frequent Carriers of Extended-Spectrum β-Lactamase (ESBL) Producing Escherichia coli of CTX-M and SHV-12 Types.
Alcalá L; Alonso CA; Simón C; González-Esteban C; Orós J; Rezusta A; Ortega C; Torres C
Microb Ecol; 2016 Nov; 72(4):861-869. PubMed ID: 26687342
[TBL] [Abstract][Full Text] [Related]
12. Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment.
Pitout JD
Expert Rev Anti Infect Ther; 2012 Oct; 10(10):1165-76. PubMed ID: 23199402
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered at two Belgian hospitals.
Bogaerts P; Rodriguez-Villalobos H; Bauraing C; Deplano A; Laurent C; Berhin C; Struelens MJ; Glupczynski Y
Pathol Biol (Paris); 2010 Feb; 58(1):78-83. PubMed ID: 19892478
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
Briñas L; Lantero M; de Diego I; Alvarez M; Zarazaga M; Torres C
J Antimicrob Chemother; 2005 Dec; 56(6):1107-10. PubMed ID: 16239288
[TBL] [Abstract][Full Text] [Related]
15. Extended-spectrum cephalosporin-resistant Escherichia coli in community, specialized outpatient clinic and hospital settings in Switzerland.
Seiffert SN; Hilty M; Kronenberg A; Droz S; Perreten V; Endimiani A
J Antimicrob Chemother; 2013 Oct; 68(10):2249-54. PubMed ID: 23759671
[TBL] [Abstract][Full Text] [Related]
16. Emergence of CMY-2-Producing Escherichia coli in Korean Layer Parent Stock.
Seo KW; Shim JB; Lee YJ
Microb Drug Resist; 2019 Apr; 25(3):462-468. PubMed ID: 30625027
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of CMY-2 producing E. coli in a broiler parent flock.
Dame-Korevaar A; Fischer EAJ; Stegeman A; Mevius D; van Essen-Zandbergen A; Velkers F; van der Goot J
Vet Microbiol; 2017 May; 203():211-214. PubMed ID: 28619146
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and characterization of extended-spectrum beta-lactamase (ESBL)- and CMY-2-producing Escherichia coli isolates from healthy food-producing animals in Tunisia.
Ben Sallem R; Ben Slama K; Sáenz Y; Rojo-Bezares B; Estepa V; Jouini A; Gharsa H; Klibi N; Boudabous A; Torres C
Foodborne Pathog Dis; 2012 Dec; 9(12):1137-42. PubMed ID: 23194332
[TBL] [Abstract][Full Text] [Related]
20. Hydrolysis spectrum extension of CMY-2-like β-lactamases resulting from structural alteration in the Y-X-N loop.
Dahyot S; Mammeri H
Antimicrob Agents Chemother; 2012 Mar; 56(3):1151-6. PubMed ID: 22232281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
